Markets
5.0
SK Biopharm Q3 Operating Profit Surges 66% on U.S. Seizure Drug Sales
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateYonhap ENLow-rated sourceKR · US
MarketsReportedLow
2.1
BioNTech swings to Q3 profit, lifts 2026 revenue guidance
BioNTech reported a $206.5M net profit in Q3, driven by lower legal expenses that offset declining COVID-19 vaccine sales. The company raised its 2026 revenue outlook, signaling improved financial health despite the vaccine revenue decline. This is a company-specific earnings event with limited macro market impact.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Score Breakdown
Mosaic Score2.1
Model confidence0.9
Significance0.1
Source credibility0.5
Related signals
8 foundMarkets
2.1
Pfizer U.S. drug sales decline on falling Covid vaccine revenue
Published 2 d ago1 sourceEvidence: Reported
SMELow-rated sourceUS
Markets
6.4
Novo Raises Full-Year Targets; Analyst Sees Gradual Turnaround
Published 1 d ago6 sourcesEvidence: Reported
SeverityModerateDagens IndustriLow-rated sourceSE
Markets
5.7
Pfizer Q3 Net Profit Falls 8%, Misses Estimates; Raises FY EPS Guidance
Published 2 d ago3 sourcesEvidence: Reported
SeverityModerateLe SoirLow-rated sourceUS
Markets
5.6
Novo Nordisk Q3 beats on Wegovy pill, but Eli Lilly lead persists
Published 1 d ago3 sourcesEvidence: Reported
SeverityModerateFDLow-rated sourceDK · US
Markets
5.2
Novo raises full-year sales forecast after Q3 beat, operating profit misses
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateDagens IndustriLow-rated sourceDK
Markets
4.8
AstraZeneca bids ~$9.7B for Rhythm Pharmaceuticals
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storyDagens IndustriLow-rated sourceSE · US
Health
4.7
Revolution Medicines' pancreatic cancer drug Rasonque posts record launch
Published 23 h ago1 sourceEvidence: Reported
SeverityModerateSTAT NewsLow-rated sourceUS